Concepedia
Statistics
Publications
6
Citations
546
H-Index
Active since
2008
Affiliations
Metrum Research Group (United States)(Current)
Takeda (United States)
University of California San Diego
Takeda (Japan)
Medical University of Vienna
Nathanael L. Dirks is an author at Metrum Research Group (United States).
Publications per year
2008–2020
Population pharmacokinetics-pharmacodynamics of vedolizumab in patients with ulcerative colitis and Crohn's disease
Maria Rosario, Nathanael L. Dirks, Marc R. Gastonguay et al. · Alimentary Pharmacology & Therapeutics · 2015 · 255 citations · Full text
Exposure–efficacy Relationships for Vedolizumab Induction Therapy in Patients with Ulcerative Colitis or Crohn’s Disease
Maria Rosario, Jonathan French, Nathanael L. Dirks et al. · Journal of Crohn s and Colitis · 2017 · 156 citations · Full text
Vedolizumab exposure levels and clinical outcomes in ulcerative colitis: determining the potential for dose optimisation
Mark T. Osterman, Maria Rosario, Karen Lasch et al. · Alimentary Pharmacology & Therapeutics · 2019 · 87 citations · Full text
Population pharmacokinetics of vedolizumab in Asian and non-Asian patients with ulcerative colitis and Crohn’s disease
Hiroyuki Okamoto, Nathanael L. Dirks, Maria Rosario et al. · Intestinal Research · 2020 · 25 citations · Full text
P490 A vedolizumab population pharmacokinetic model including intravenous and subcutaneous formulations for patients with ulcerative colitis
Maria Rosario, Dan Polhamus, C Chen et al. · Journal of Crohn s and Colitis · 2019 · 12 citations · Full text
1–5 of 6